Skip to main content

Table 2 Ciprofloxacin number of doses used, minimum inhibitory concentration (MICs) and mechanisms of fluoroquinolone resistance detected among 18 Enterobacteriaceae strains isolated from 16 men undergoing transrectal ultrasound-guided prostate biopsy

From: The molecular mechanisms of fluoroquinolone resistance found in rectal swab isolates of Enterobacterales from men undergoing a transrectal prostate biopsy: the rationale for targeted prophylaxis

Isolate no

Species

Date of isolation

Antibiotic-course treatment and number of doses

MIC CIP (mg/L)

Mutation(s)

PMQRs

GyrA

GyrB

ParC

ParE

9 I

E. coli

4.12.2015

1 × Cip

0.25

M605L

qnrS1

10 I

E. coli

11.12.2015

1 × Cip

0.25

S83L

qnrS1

40

E. coli

25.03.2016

1 × Cip

0.25

V461E

qnrS1

41

E. coli

25.03.2016

1 × Cip

0.5

S83L

S80R

10 II

E. cloaceae

11.12.2015

1 × Cip

2

S83F

A512T

qnrS1

6

E. coli

4.12.2015

5 × Cip

6

S83L

D87N

S80I

11

E. coli

11.12.2015

3 × Cip

8

S83L

D87N

S80I

14

E. coli

15.01.2016

5 × Cip

8

S83L

E84G

qnrS1

42

E. coli

25.03.2016

2 × Cip

8

S83L

D87N

S80I

18 I

E. coli

23.01.2016

1 × Cip

12

S83L

D87N

S80I

34 I

E. coli

11.03.2016

12 × Cip

12

S83L

D87N

S80I

qnrS

20

E. coli

5.02.2016

1 × Cip

24

S83L

D87N

S80I

38

E. coli

18.03.2016

2 × Cip

24

S83L

D87N

S80I

33

E. coli

11.03.2016

4 × Cip

32

S83L

D87N

S80I

qnrS1

12

E. coli

11.12.2015

3 × Cip

 > 32

S83L

D87N

S80I

E84M

28

E. coli

4.03.2016

3 × Cip

 > 32

S83L

D87N

S80I

E84V

qnrS

34 II

E. coli

11.03.2016

12 × Cip

 > 32

S83L

D87N

S80I

S458A

43

E. coli

25.03.2016

10 × Cip

 > 32

S83L

D87N

S80R

E84K

qnrS2

  1. Cip ciprofloxacin